x
Filter:
Filters applied
- Melanoma
- HRRemove HR filter
- overall survivalRemove overall survival filter
Author
- Amos, Christopher I1
- Bassett, Roland L1
- Cormier, Janice N1
- Dang, Yifang1
- Davies, Michael A1
- Eigentler, Thomas Kurt1
- Fang, Shenying1
- Fiedler, Eckhard1
- Gagel, Andrew1
- Garbe, Claus1
- Gassenmaier, Maximilian1
- Gershenwald, Jeffrey E1
- Goebeler, Matthias1
- Grischke, Eva-Maria1
- Haydu, Lauren E1
- Keim, Ulrike1
- Lee, Jeffrey E1
- Leiter, Ulrike1
- Martus, Peter1
- McQuade, Jennifer L1
- Reveille, John D1
- Ross, Merrick I1
- Schuler, Gerold1
- Sui, Dawen1
- Wang, Yuling1
Keyword
- CI2
- confidence interval2
- hazard ratio2
- melanoma-specific survival2
- MSS2
- OS2
- BMI1
- body mass index1
- C-reactive protein1
- CLND1
- complete lymph node dissection1
- CRP1
- DFS1
- disease-free survival1
- distant metastasis-free survival1
- DMFS1
- interquartile range1
- IQR1
- sentinel lymph node biopsy1
- single-nucleotide polymorphism1
- SLNB1
- SNP1
- TANS1
Melanoma
2 Results
- Original Article Melanocytes/MelanomaOpen Archive
Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry
Journal of Investigative DermatologyVol. 137Issue 12p2570–2577Published online: July 20, 2017- Maximilian Gassenmaier
- Thomas Kurt Eigentler
- Ulrike Keim
- Matthias Goebeler
- Eckhard Fiedler
- Gerold Schuler
- and others
Cited in Scopus: 17For more than a century the Halstedian hypothesis of contiguous metastasis from the primary tumor through the lymphatics to distant sites shaped lymph node surgery for melanoma. We challenge this dogma of serial metastatic dissemination. A single-center series of 2,299 patients with cutaneous metastatic melanoma was investigated to analyze overall survival and distant metastasis-free survival of stage IV patients with or without primary lymphatic metastasis. Results were then compared with those of 2,134 patients from three independent centers of the German Central Malignant Melanoma Registry. - Letter to the EditorOpen Archive
Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes
Journal of Investigative DermatologyVol. 137Issue 8p1792–1795Published online: April 22, 2017- Shenying Fang
- Yuling Wang
- Yifang Dang
- Andrew Gagel
- Merrick I. Ross
- Jeffrey E. Gershenwald
- and others
Cited in Scopus: 31Obesity is a known risk factor for cancer development (Arnold et al., 2016; Basen-Engquist and Chang, 2011; Renehan et al., 2015) and death (Calle et al., 2003). Obesity has been associated with an increased risk of developing melanoma in men (Sergentanis et al., 2013) and with thicker primary melanomas (Skowron et al., 2015). The inflammatory adipokine leptin promotes melanoma progression in mice (Amjadi et al., 2011; Brandon et al., 2009; Gogas et al., 2008); elevated leptin levels may predict melanoma sentinel node metastasis (Oba et al., 2016).